1. bookVolume 2 (2019): Issue 1 (April 2019)
Journal Details
License
Format
Journal
eISSN
2601-9388
First Published
30 Sep 2018
Publication timeframe
2 times per year
Languages
English
access type Open Access

The prevalence of Beta Hemolytic Streptococcus in a Children’s Tertiary Care Hospital in Timisoara

Published Online: 04 May 2019
Volume & Issue: Volume 2 (2019) - Issue 1 (April 2019)
Page range: 73 - 78
Received: 02 Feb 2019
Accepted: 06 Apr 2019
Journal Details
License
Format
Journal
eISSN
2601-9388
First Published
30 Sep 2018
Publication timeframe
2 times per year
Languages
English
Abstract

Background. Beta hemolytic streptococcus (BHS) represents a worldwide health problem because of the complications that can occur. Thus, it is important to identify the presence and type of BHS in time to start treatment if needed, avoiding the complications.

Aim. Our aim was to identify the prevalence of Beta Hemolytic Streptococcus in a Children’s Tertiary Care Hospital in Timisoara.

Methods. A cross-sectional study was conducted from April-June 2018 in Emergency Hospital for Children Timisoara. The study lot consists from 1100 children, ages between 0-18 years, which were not given, in the preceding two weeks, any antibiotics. We compared the study with two studies from different cities in Nepal, with the same subject as ours. Group A and Group C Streptococci were identified by beta hemolytic colonies, bacitracin sensitivity, catalase negativity test and latex agglutination test (Oxoid Streptococcal Grouping kit). ASO (Antistreptolysin O) test was also performed from serum samples, for patients with positive cultures. We also tested the antibiotic sensitivity to: Cefepime, Clindamycin, Erythromycin, Tetracycline.

Results. The prevalence of BHS (Beta Hemolytic Streptococcus), especially GABHS (Group A Beta Hemolytic Streptococcus) was 4%, in children from a tertiary care hospital in Timisoara, Romania; which is comparable to the findings of similar studies. In the first study, the prevalence of GABHS was 7.2%, and in the second study was 9%. The patients with positive cultures were also tested for ASO, 28 patients (52%) had high levels, while 26 (48%) had normal levels. On all positive patients an antibiogram was made and we observed that most of the isolates were sensitive to the antibiotics used. A few isolates in Group A were resistant.

Conclusions. Considering the limited data found on our subject, further epidemiological studies on streptococcal disease complex are needed.

Keywords

1. Anon. Nosocomial group A streptococcal infections associated with asymptomatic health-care workers - Maryland and California. MMWR 1997Search in Google Scholar

2. Cynthia S. Hayes, Harold Williamson. Management of Group A Beta-Hemolytic Streptococcal Pharyngitis. Am Fam Physician. 2001 Apr 15;63(8):1557-1565Search in Google Scholar

3. Roxana Moldovan. Practical Bacteriology. Mirton. Timisoara.1998Search in Google Scholar

4. Manandhar A, Shah Y, Shrestha J. Study on the Prevalence of Beta Haemolytic Streptococcus Among School Children. J Nepal Paediatr Soc. 2013;33(1):45-4710.3126/jnps.v33i1.7004Search in Google Scholar

5. Patterson MJ. Streptococcus. Medical Microbiology. 4th edition. Galveston, 1996.Search in Google Scholar

6. M.S.Sahin, M.U.Yalcin, D.Kocyigit. Prevalence of rheumatic heart disease in patients with recurrent tonsillitis and elevated anti-streptolysin O titers. International Journal of Pediatric Otorhinolaryngology. October 2016; 89:133-135Search in Google Scholar

7. Delia Muntean, Florin-George Horhat, Luminița Bădițoiu, Victor Dumitrașcu, Iulia-Cristina Bagiu, Delia-Ioana Horhat et. al. Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit. Medicina 2018;54(6), 9210.3390/medicina54060092Search in Google Scholar

8. Tsegahun Asfaw, Demissew Shenkute, Mihret Tilahun, Nigus Zegeye. Evaluation of Antistreptolysin O (ASO) Titer in Rheumatoid Heart Disease Debre Berhan Referral Hospital, Ethiopia.Clinical Medicine Research 2018; 7(1): 26-2910.11648/j.cmr.20180701.14Search in Google Scholar

9. Shaikh N, Leonard E, Martin JM. Prevalence of Streptococcal Pharyngitis and Streptococcal Carriage in Children: A Meta-analysis. Pediatrics. 2010;126(3):557-564.10.1542/peds.2009-2648Search in Google Scholar

10. Hurst JR, Kasper KJ, Sule AN, McCormick JK. Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited. Infect Genet Evol. 2018;61(March):160-175.10.1016/j.meegid.2018.03.006Search in Google Scholar

11. Bonofiglio L, Gagetti P, García Gabarrot G, et al. Susceptibility to β-lactams in β-hemolytic streptococci. Rev Argent Microbiol. 201810.1016/j.ram.2017.11.002Search in Google Scholar

12. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-694.10.1016/S1473-3099(05)70267-XSearch in Google Scholar

13. Brook I. Brief Report A Pooled Comparison of Cefdinir and Penicillin in the Treatment of Group A beta-hemolytic Streptococcal Pharyngotonsillitis. 2005:3-10.10.1016/j.clinthera.2005.08.00316199251Search in Google Scholar

14. Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey: 2002 summary. Adv Data. 2004;(346):1-44.Search in Google Scholar

15. Bisno AL, Gerber MA, Gwaltney, Jr. JM, Kaplan EL, Schwartz RH, Infectious Diseases Society of America. Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis. Clin Infect Dis. 2002;35(2):113-125.10.1086/34094912087516Search in Google Scholar

16. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470-511.10.1128/CMR.13.3.4708894410885988Search in Google Scholar

17. Shrestha L, Khattri J B K, Brahmadathan K N, Nagra J S, Prevalence Of Streptococcal Pharyngitis Among School Children Of Pokhara Valley, Nepal, Journal of Nepal Medical Association, 2001:41:253-25710.31729/jnma.737Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo